Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-26-036228
Filing Date
2026-03-27
Accepted
2026-03-27 17:10:17
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2610096-3_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2610096-3_3aseq1.xml 3/A 13357
2 EXHIBIT 24.1 tm2610096d3_ex24-1.htm EX-24.1 6825
  Complete submission text file 0001104659-26-036228.txt   21802
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM Denmark
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM Denmark 4552656554
Evaxion A/S (Issuer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address DR. NEERGAARDS VEJ 5F HORSHOLM Denmark DK-2970
Business Address
Rono Birgitte (Reporting) CIK: 0002124546 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39950 | Film No.: 26808501